Wall Street Analysts See an 86.45% Upside in Biodesix (BDSX): Can the Stock Really Move This High?

The mean of analysts' price targets for Biodesix (BDSX) points to an 86.5% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.